These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27613235)

  • 1. Type I interferon responses are impaired in latently HIV infected cells.
    Ranganath N; Sandstrom TS; Fadel S; Côté SC; Angel JB
    Retrovirology; 2016 Sep; 13(1):66. PubMed ID: 27613235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct.
    Muto NF; Martinand-Mari C; Adelson ME; Suhadolnik RJ
    J Virol; 1999 Nov; 73(11):9021-8. PubMed ID: 10516008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune regulation in HIV latency models.
    Olson RM; Gornalusse G; Whitmore LS; Newhouse D; Tisoncik-Go J; Smith E; Ochsenbauer C; Hladik F; Gale M
    Retrovirology; 2022 Jul; 19(1):15. PubMed ID: 35804422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V; Zeichner SL
    J Virol; 2004 Sep; 78(17):9458-73. PubMed ID: 15308739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency.
    Telwatte S; Morón-López S; Aran D; Kim P; Hsieh C; Joshi S; Montano M; Greene WC; Butte AJ; Wong JK; Yukl SA
    Retrovirology; 2019 Nov; 16(1):32. PubMed ID: 31711503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two candidate genes, NCoA3 and IRF8, potentially involved in the control of HIV-1 latency.
    Munier S; Delcroix-Genête D; Carthagéna L; Gumez A; Hazan U
    Retrovirology; 2005 Nov; 2():73. PubMed ID: 16305739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected With HIV-1: Implications for an HIV Cure.
    Ranganath N; Sandstrom TS; Burke Schinkel SC; Côté SC; Angel JB
    J Infect Dis; 2018 Feb; 217(5):721-730. PubMed ID: 29228368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.
    Taura M; Kudo E; Kariya R; Goto H; Matsuda K; Hattori S; Vaeteewoottacharn K; McDonald F; Suico MA; Shuto T; Kai H; Okada S
    J Virol; 2015 Mar; 89(5):2643-58. PubMed ID: 25520503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells?
    Biswas P; Poli G; Orenstein JM; Fauci AS
    J Virol; 1994 Apr; 68(4):2598-604. PubMed ID: 7511175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-induced interleukin-8 production is depressed in chronic as opposed to acute human immunodeficiency virus 1 infection of promonocytic cells.
    Tiemessen CT; Martin DJ
    Acta Virol; 2000; 44(3):193-8. PubMed ID: 11155365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication.
    Sandstrom TS; Ranganath N; Angel JB
    Cytokine Growth Factor Rev; 2017 Oct; 37():1-16. PubMed ID: 28455216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.
    Rasmussen TA; Schmeltz Søgaard O; Brinkmann C; Wightman F; Lewin SR; Melchjorsen J; Dinarello C; Østergaard L; Tolstrup M
    Hum Vaccin Immunother; 2013 May; 9(5):993-1001. PubMed ID: 23370291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of interferon-alpha on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells.
    Ohashi K; Akazawa R; Kurimoto M
    J Interferon Res; 1994 Jun; 14(3):129-32. PubMed ID: 7930759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
    de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
    Front Immunol; 2021; 12():720697. PubMed ID: 34531866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of E. coli-derived endonuclease MazF suppresses HIV-1 production and causes apoptosis in latently infected cells.
    Okamoto M; Chono H; Hidaka A; Toyama M; Mineno J; Baba M
    Biochem Biophys Res Commun; 2020 Sep; 530(3):597-602. PubMed ID: 32747090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB.
    Yang X; Chen Y; Gabuzda D
    J Biol Chem; 1999 Sep; 274(39):27981-8. PubMed ID: 10488148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for macrophage-mediated HIV-1 induction.
    Devadas K; Hardegen NJ; Wahl LM; Hewlett IK; Clouse KA; Yamada KM; Dhawan S
    J Immunol; 2004 Dec; 173(11):6735-44. PubMed ID: 15557166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site.
    Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I
    J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
    Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells.
    Ickler J; Francois S; Widera M; Santiago ML; Dittmer U; Sutter K
    PLoS One; 2020; 15(1):e0218905. PubMed ID: 31935222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.